G. Trinchieri, Biology of Natural Killer Cells, Adv Immunol, vol.47, pp.187-376, 1989.
DOI : 10.1016/S0065-2776(08)60664-1

L. Moretta and A. Moretta, Unravelling natural killer cell function: triggering and inhibitory human NK receptors, The EMBO Journal, vol.23, issue.2, pp.255-259, 2004.
DOI : 10.1038/sj.emboj.7600019
URL : http://emboj.embopress.org/content/embojnl/23/2/255.full.pdf

M. Caligiuri, Human natural killer cells, Blood, vol.112, issue.3, pp.461-469, 2008.
DOI : 10.1182/blood-2007-09-077438
URL : https://hal.archives-ouvertes.fr/hal-00431858

L. Moretta, C. Bottino, D. Pende, R. Castriconi, and M. Mingari, Surface NK receptors and their ligands on tumor cells, Seminars in Immunology, vol.18, issue.3, pp.151-158, 2006.
DOI : 10.1016/j.smim.2006.03.002

L. Moretta and A. Moretta, Killer immunoglobulin-like receptors, Current Opinion in Immunology, vol.16, issue.5, pp.626-633, 2004.
DOI : 10.1016/j.coi.2004.07.010
URL : https://hal.archives-ouvertes.fr/hal-00079731

M. Lopez-botet, M. Mc, T. Tb, J. Perez-villar, and M. Llano, The CD94/ NKG2 C-type lectin receptor complex, Curr Top Microbiol Immunol, vol.230, pp.41-52, 1998.

E. Long, REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS, Annual Review of Immunology, vol.17, issue.1, pp.875-904, 1999.
DOI : 10.1146/annurev.immunol.17.1.875

M. Kornstein, R. Stewart, and D. Elder, Natural killer cells in the host response to melanoma, Cancer Res, vol.47, pp.1411-1412, 1987.

J. Schleypen, N. Baur, R. Kammerer, P. Nelson, and K. Rohrmann, Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma, Clinical Cancer Research, vol.12, issue.3, pp.718-725, 2006.
DOI : 10.1158/1078-0432.CCR-05-0857

K. Mckay, P. Moore, B. Smoller, and K. Hiatt, Association between natural killer cells and regression in melanocytic lesions, Human Pathology, vol.42, issue.12, pp.1960-1964, 2011.
DOI : 10.1016/j.humpath.2011.02.019

L. Ferradini, A. Mackensen, C. Genevee, J. Bosq, and P. Duvillard, Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion., Journal of Clinical Investigation, vol.91, issue.3, pp.1183-1190, 1993.
DOI : 10.1172/JCI116278

M. Movassagh, A. Spatz, J. Davoust, S. Lebecque, and P. Romero, Dendritic Cells in Tumor Sites Is Associated with Efficient T-Cell-Mediated Antitumor Response and Control of Metastatic Dissemination in Melanoma, Cancer Research, vol.64, issue.6, pp.2192-2198, 2004.
DOI : 10.1158/0008-5472.CAN-03-2969

E. Wang, G. Phan, and F. Marincola, T-cell-directed cancer vaccines: the melanoma model, Expert Opinion on Biological Therapy, vol.92, issue.402, pp.277-290, 2001.
DOI : 10.1006/smim.1998.0143

G. Fregni, A. Perier, G. Pittari, S. Jacobelli, and X. Sastre, Unique Functional Status of Natural Killer Cells in Metastatic Stage IV Melanoma Patients and Its Modulation by Chemotherapy, Clinical Cancer Research, vol.17, issue.9, pp.2628-2637, 2011.
DOI : 10.1158/1078-0432.CCR-10-2084

J. Zhu, X. Wang, X. Xu, and Y. Abassi, Dynamic and label-free monitoring of natural killer cell cytotoxic activity using electronic cell sensor arrays, Journal of Immunological Methods, vol.309, issue.1-2, pp.25-33, 2006.
DOI : 10.1016/j.jim.2005.10.018

A. Perier, G. Fregni, S. Wittnebel, S. Gad, and M. Allard, Mutations of the von Hippel???Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma, Oncogene, vol.309, issue.23, pp.2622-2632, 2011.
DOI : 10.1016/j.jim.2005.10.018

S. Platonova, J. Cherfils-vicini, D. Damotte, L. Crozet, and V. Vieillard, Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma, Cancer Research, vol.71, issue.16, pp.5412-5422, 2011.
DOI : 10.1158/0008-5472.CAN-10-4179

G. Pittari, G. Fregni, L. Roguet, A. Garcia, and A. Vataire, Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients, Bone Marrow Transplantation, vol.10, issue.5, pp.862-871, 2010.
DOI : 10.1182/blood-2004-10-4035

M. Martinovic, K. Konjevic, G. Babovic, N. Inic, and M. , The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients, Journal of Surgical Research, vol.171, issue.2, pp.637-649, 2011.
DOI : 10.1016/j.jss.2010.05.012

G. Konjevic, M. Martinovic, K. Vuletic, A. Jovic, V. Jurisic et al., Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients, Clinical & Experimental Metastasis, vol.95, issue.5, pp.1-11, 2007.
DOI : 10.4049/jimmunol.168.2.671

G. Konjevic, M. Martinovic, K. Vuletic, A. Radenkovic, and S. , Novel aspects of in vitro IL-2 or IFN-?? enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction, Biomedicine & Pharmacotherapy, vol.64, issue.10, pp.663-671, 2010.
DOI : 10.1016/j.biopha.2010.06.013

E. Mamessier, A. Sylvain, F. Bertucci, R. Castellano, and P. Finetti, Human Breast Tumor Cells Induce Self-Tolerance Mechanisms to Avoid NKG2D-Mediated and DNAM-Mediated NK Cell Recognition, Cancer Research, vol.71, issue.21, pp.6621-6632, 2011.
DOI : 10.1158/0008-5472.CAN-11-0792

G. Fregni, A. Perier, M. Avril, and A. Caignard, NK cells sense tumors, course of disease and treatments, OncoImmunology, vol.11, issue.1, pp.38-47, 2012.
DOI : 10.1182/blood-2004-07-2974

C. Vetter, P. Straten, P. Terheyden, J. Zeuthen, and E. Brocker, Expression of CD94/NKG2 Subtypes on Tumor-Infiltrating Lymphocytes in Primary and Metastatic Melanoma, Journal of Investigative Dermatology, vol.114, issue.5, pp.941-947, 2000.
DOI : 10.1046/j.1523-1747.2000.00958.x

G. Erdag, J. Schaefer, M. Smolkin, D. Deacon, and S. Shea, Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma, Cancer Research, vol.72, issue.5, 2012.
DOI : 10.1158/0008-5472.CAN-11-3218

R. Remark, M. Alifano, I. Cremer, A. Lupo, and M. Dieu-nosjean, Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin, Clinical Cancer Research, vol.19, issue.15, 2013.
DOI : 10.1158/1078-0432.CCR-12-3847

S. Rusakiewicz, M. Semeraro, M. Sarabi, M. Desbois, and C. Locher, Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors, Cancer Research, vol.73, issue.12, pp.3499-3510, 2013.
DOI : 10.1158/0008-5472.CAN-13-0371

A. Glasner, H. Ghadially, C. Gur, N. Stanietsky, and P. Tsukerman, Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1, The Journal of Immunology, vol.188, issue.6, pp.2509-2515, 2012.
DOI : 10.4049/jimmunol.1102461

G. Halfteck, M. Elboim, C. Gur, H. Achdout, and H. Ghadially, Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1, The Journal of Immunology, vol.182, issue.4, pp.2221-2230, 2009.
DOI : 10.4049/jimmunol.0801878

E. Cagnano, O. Hershkovitz, A. Zilka, A. Bar-ilan, and A. Golder, Expression of Ligands to NKp46 in Benign and Malignant Melanocytes, Journal of Investigative Dermatology, vol.128, issue.4, pp.972-979, 2008.
DOI : 10.1038/sj.jid.5701111

J. Elliott, J. Wahle, and W. Yokoyama, MHC class I???deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I???sufficient environment, The Journal of Experimental Medicine, vol.1, issue.10, pp.2073-2079, 2010.
DOI : 10.1084/jem.194.10.1531

N. Joncker, N. Shifrin, F. Delebecque, and D. Raulet, Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment, The Journal of Experimental Medicine, vol.158, issue.10, pp.2065-2072, 2010.
DOI : 10.1038/342435a0

J. Sun, J. Beilke, N. Bezman, and L. Lanier, Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection, The Journal of Experimental Medicine, vol.2, issue.2, pp.357-368, 2011.
DOI : 10.1146/annurev.immunol.22.012703.104711

T. Lakshmikanth, S. Burke, T. Ali, S. Kimpfler, and F. Ursini, NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo, Journal of Clinical Investigation, vol.119, issue.5, 2009.
DOI : 10.1172/JCI36022DS1

D. Chiesa, M. Carlomagno, S. Frumento, G. Balsamo, M. Cantoni et al., The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function, Blood, vol.108, issue.13, pp.4118-4125, 2006.
DOI : 10.1182/blood-2006-03-006700

G. Pietra, C. Manzini, S. Rivara, M. Vitale, and C. Cantoni, Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity, Cancer Research, vol.72, issue.6, 2012.
DOI : 10.1158/0008-5472.CAN-11-2544

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, and J. Soulillou, Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, pp.2806-2814, 2007.
DOI : 10.1182/blood-2006-06-030213

M. Allard, R. Oger, V. Vignard, J. Percier, and G. Fregni, Serum Soluble HLA-E in Melanoma: A New Potential Immune-Related Marker in Cancer, PLoS ONE, vol.87, issue.1, 2011.
DOI : 10.1371/journal.pone.0021118.t002
URL : https://hal.archives-ouvertes.fr/inserm-01234644

M. Mccarter, C. J. Richter, D. Wilson, and C. , Melanoma skews dendritic cells to facilitate a T helper 2 profile, Surgery, vol.138, issue.2, pp.321-328, 2005.
DOI : 10.1016/j.surg.2005.06.011

E. Godefroy, O. Manches, B. Dreno, T. Hochman, and L. Rolnitzky, Matrix Metalloproteinase-2 Conditions Human Dendritic Cells to Prime Inflammatory TH2 Cells via an IL-12- and OX40L-Dependent Pathway, Cancer Cell, vol.19, issue.3, pp.333-346, 2011.
DOI : 10.1016/j.ccr.2011.01.037

G. Miller, S. Lahrs, and R. Dematteo, Overexpression of interleukin-12 enables dendritic cells to activate NK cells and confer systemic antitumor immunity, The FASEB Journal, vol.17, pp.728-730, 2003.
DOI : 10.1096/fj.02-0900fje

J. Wong, R. Mailliard, S. Moschos, H. Edington, and M. Lotze, Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells, Journal of Immunotherapy, vol.34, issue.3, pp.270-278, 2011.
DOI : 10.1097/CJI.0b013e31820b370b

K. Flaherty, I. Puzanov, K. Kim, A. Ribas, and G. Mcarthur, Inhibition of Mutated, Activated BRAF in Metastatic Melanoma, New England Journal of Medicine, vol.363, issue.9, pp.809-819, 2010.
DOI : 10.1056/NEJMoa1002011